Skip to main content

Katie

Analyst

HC Wainwright & Co.

Equibles does not estimate personal net worth.

About Katie

Katie is recorded as Analyst at HC Wainwright & Co.. Katie has spoken on 2 earnings calls across 2 companies, most recently for Inovio Pharmaceuticals, Inc. on August 12, 2026. Those appearances were for Inovio Pharmaceuticals, Inc. (INO) and Co-Diagnostics, Inc. (CODX). The companies whose calls Katie spoke on are classified in the Healthcare sector.

Katie on recent calls

“Should investors expect another capital raise before the PDUFA, or is the plan to bridge launch through Revenue and Financing Partner?”
Analyst — HC Wainwright & Co., INOVIO Second Quarter 2026 Financial Results Conference Call ·
“Looking at your now three-target test, dropping COVID seems like a great idea. Where does the sample accrual stand for the three-target panel? Is first half of 26 still the target?”
Analyst — HC Wainwright & Co., Co-Diagnostics, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • HC Wainwright & Co.

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity